Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2022 · 10-Q
Revenue$7.81M$7.81M+55.9% vs Q1 2021 Net Income-$3.13M-$3.13MN/M vs Q1 2021 EPS, diluted—
Gross Profit$7,006,142+54.5% Operating Income-$2,776,872N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$2,112,478N/M Free Cash Flowderived-$2,157,175N/M Margins · derivedGross margin89.7%−0.8 pt vs Q1 2021
Operating margin-35.5%−13.9 pt vs Q1 2021
Net margin-40.1%−16.4 pt vs Q1 2021
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end